Lack of reduction in buprenorphine injection after introduction of co-formulated buprenorphine/naloxone to the Malaysian market

Background: Diversion of buprenorphine (BPN) has been described in settings where it is legally prescribed and has resulted in increasing concern. To address this concern, co-formulation of buprenorphine/naloxone (BPN/NLX) replaced buprenorphine alone in Malaysia in December 2006. Methods: To assess...

Full description

Bibliographic Details

Main Authors:	Bruce, R.D., Govindasamy, S., Sylla, L., Kamarulzaman, A., Altice, F.L.
Format:	Article
Language:	en
Published:	2009
Subjects:	R Medicine
Online Access:	http://eprints.um.edu.my/4596/1/Lack_of_Reduction_in_Buprenorphine_Injection_After_Introduction_of_Co-Formulated_Buprenorphine-Naloxone_to_the_Malaysian_Market.pdf http://eprints.um.edu.my/4596/
Tags:	Add Tag No Tags, Be the first to tag this record!